"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something ...
…
continue reading
1
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
56:33
56:33
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
56:33
Vineeta Agarwala, general partner at A16Z's Bio & Health fund, on investing in AI for drug discovery.द्वारा Timmerman Report
…
continue reading
1
Ep156: David Liu on New Tools and Techniques for Biology
1:52:57
1:52:57
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:52:57
David Liu, professor of chemistry at Harvard University and co-founder of multiple biotech companies, including Beam Therapeutics and Prime Medicine.द्वारा Timmerman Report
…
continue reading
1
Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's
1:02:37
1:02:37
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:02:37
Valerie Daggett, founder and CEO of Seattle-based AltPep, on early detection and treatment of Alzheimer's.द्वारा Timmerman Report
…
continue reading
1
Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
1:03:14
1:03:14
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:03:14
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.द्वारा Timmerman Report
…
continue reading
1
Ep153: Rick Young on Studying Gene Expression for Drug Discovery
1:01:43
1:01:43
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:01:43
Rick Young, professor at MIT and co-founder of Syros Pharmaceuticals, CAMP4 Therapeutics, Omega Therapeutics, and Dewpoint Therapeutics, on studying gene expression for drug discovery.द्वारा Timmerman Report
…
continue reading
1
Ep152: Jens Eckstein on Investing in Healthy Aging
1:05:05
1:05:05
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:05:05
Jens Eckstein, investment partner at Hevolution Foundation, on investing in healthy aging.द्वारा Timmerman Report
…
continue reading
1
Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer
1:03:55
1:03:55
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:03:55
Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.द्वारा Timmerman Report
…
continue reading
1
Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance
1:03:48
1:03:48
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:03:48
Jeff Jonker, CEO of San Diego-based Belharra Therapeutics, on the renaissance in small molecule drug discovery.द्वारा Timmerman Report
…
continue reading
1
Ep149: Nancy Stagliano on Precision Neuroscience
1:01:53
1:01:53
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:01:53
Nancy Stagliano, CEO of South San Francisco-based Neuron23, on bringing precision medicine to neuroscience drug discovery.द्वारा Timmerman Report
…
continue reading
1
Ep148: Diana Brainard on the Fight Against Infectious Disease
1:03:27
1:03:27
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:03:27
Diana Brainard, CEO of AlloVir, on leading the fight against infectious diseases.द्वारा Timmerman Report
…
continue reading
1
Ep147: Reid Huber on Investing in the Future of Medicine
1:08:41
1:08:41
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:08:41
Reid Huber, partner at Third Rock Ventures, on investing in the future of medicine.द्वारा Timmerman Report
…
continue reading
1
Ep146: Jeff Huber on Life in Tech and Biotech
1:47:05
1:47:05
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:47:05
Jeff Huber, co-founder and general partner at Triatomic Capital, on his career path in tech, and then biotech.द्वारा Timmerman Report
…
continue reading
1
Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer
1:06:39
1:06:39
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:06:39
Lori Lyons-Williams, CEO of Abdera Therapeutics, on developing targeted radiopharmaceuticals for cancer.द्वारा Timmerman Report
…
continue reading
1
Ep144: Turning the Tables, Rob Perez Interviews Me
1:04:58
1:04:58
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:04:58
Turning the Tables, Rob Perez Interviews Meद्वारा Timmerman Report
…
continue reading
1
Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders
1:10:25
1:10:25
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:10:25
Zach Weinberg and Alexis Borisy of Curie.Bio on Freeing the Biotech Foundersद्वारा Timmerman Report
…
continue reading
1
Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be
55:54
55:54
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
55:54
Fred Appelbaum, a physician, scientist and leader at the Fred Hutchinson Cancer Center, on 'Living Medicine,' his new book about the development of bone marrow transplantation and the rise of cell therapy.द्वारा Timmerman Report
…
continue reading
1
Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets
1:09:30
1:09:30
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:09:30
Colin Hill, co-founder and CEO of Aitia, on digging deep into biological datasets and finding new drug targets.द्वारा Timmerman Report
…
continue reading
1
Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas
1:02:40
1:02:40
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:02:40
Yung Lie, president and CEO of Damon Runyon Cancer Research Foundation, on advancing cancer research by supporting young scientists with bold and brave ideas.द्वारा Timmerman Report
…
continue reading
1
Ep139: Kevin Conroy on Early Detection of Cancer
1:08:28
1:08:28
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:08:28
Kevin Conroy, CEO of Exact Sciences, on early detection of cancer.द्वारा Timmerman Report
…
continue reading
1
Ep138: Jodie Morrison on Becoming a Biotech CEO
1:00:17
1:00:17
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:00:17
Jodie Morrison, acting CEO of Q32Bio, on becoming a biotech CEO.द्वारा Timmerman Report
…
continue reading
1
Ep137: Aaron Ring on Immunotherapy for Cancer & More
56:37
56:37
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
56:37
Aaron Ring, a scientist at Yale moving to the Fred Hutchinson Cancer Center, on applying immunology and protein engineering for cancer therapy and more.द्वारा Timmerman Report
…
continue reading
1
Ep136: Deborah Palestrant on Building Biotech Startups
52:52
52:52
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
52:52
Deborah Palestrant, partner at 5AM Ventures and head of the 4:59 initiative, on building biotech startups.द्वारा Timmerman Report
…
continue reading
1
Ep135: John Maraganore on Developing a New Class of Medicines
1:03:51
1:03:51
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:03:51
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.द्वारा Timmerman Report
…
continue reading
1
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
1:16:22
1:16:22
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:16:22
Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.द्वारा Timmerman Report
…
continue reading
1
Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies
1:10:33
1:10:33
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:10:33
Catherine Stehman-Breen, CEO of Boston-based Chroma Medicine, on developing epigenetic editing therapies.द्वारा Timmerman Report
…
continue reading
1
Ep132: Eric Dobmeier on Treating Kidney Disease
1:05:44
1:05:44
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:05:44
Eric Dobmeier, CEO of Seattle-based Chinook Therapeutics, on new strategies for treating kidney diseases.द्वारा Timmerman Report
…
continue reading
1
Ep131: Ryan Watts on Neuroscience Drug R&D
1:05:32
1:05:32
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:05:32
Ryan Watts, CEO of South San Francisco-based Denali Therapeutics, on neuroscience drug discovery and development.द्वारा Timmerman Report
…
continue reading
1
Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave
1:09:29
1:09:29
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:09:29
David Hallal, CEO of ElevateBio, on a long career in biotech and the coming 50-year opportunity in cell therapy and gene therapy.द्वारा Timmerman Report
…
continue reading
1
Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies
1:11:43
1:11:43
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:11:43
Joanne Smith-Farrell, CEO of Cambridge, Mass.-based Be Biopharma, on Engineered B-Cell Therapies for Cancer & Rare Diseases.द्वारा Timmerman Report
…
continue reading
1
Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last
1:00:34
1:00:34
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:00:34
Rick Berke, co-founder and executive editor of STAT, on building a biotech journalism outlet to last.द्वारा Timmerman Report
…
continue reading
1
Ep127: Jeb Keiper on Computational Drug Discovery
1:09:41
1:09:41
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:09:41
Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.द्वारा Timmerman Report
…
continue reading
1
Ep126: DA Wallach on Becoming a Biotech VC
1:11:38
1:11:38
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:11:38
DA Wallach, founder and general partner of TIME Bioventures, on becoming a biotech venture investor.द्वारा Timmerman Report
…
continue reading
1
Ep125: Barry Greene on a New Drug for Depression
1:04:52
1:04:52
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:04:52
Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.द्वारा Timmerman Report
…
continue reading
1
Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines
1:09:53
1:09:53
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:09:53
Shehnaaz Suliman, CEO of ReCode Therapeutics, on lipid nanoparticle delivery of genetic medicines.द्वारा Timmerman Report
…
continue reading
1
Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery
1:15:26
1:15:26
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:15:26
Tariq Kassum, CEO of Cambridge, Mass.-based Celsius Therapeutics, on using single cell technology for drug discovery.द्वारा Timmerman Report
…
continue reading
1
Ep122: Aetna Wun Trombley on Extracellular Protein Degraders
1:00:04
1:00:04
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:00:04
Aetna Wun Trombley, CEO of Lycia Therapeutics, on extracellular protein degraders.द्वारा Timmerman Report
…
continue reading
1
Ep121: Samantha Truex on Going Upstream Against Severe Asthma
1:03:49
1:03:49
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:03:49
Samantha Truex, CEO of Upstream Bio, on a new approach to treating severe asthma and other inflammatory diseases.द्वारा Timmerman Report
…
continue reading
1
Ep120: Tim Lu on Gene Circuits for Cell Therapy
1:04:14
1:04:14
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:04:14
Tim Lu, CEO of Senti Biosciences, on developing gene circuits for cell therapy.द्वारा Timmerman Report
…
continue reading
1
Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease
1:02:42
1:02:42
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:02:42
Jo Viney, CEO of Seismic Therapeutic, on discovering new treatments for autoimmune disease.द्वारा Timmerman Report
…
continue reading
1
Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes
1:08:08
1:08:08
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:08:08
Ivan Liachko, CEO of Seattle-based Phase Genomics, on assembling accurate genomes and interactomes. He also discusses immigrating from Ukraine as a child, and what brought him and his family to the US.द्वारा Timmerman Report
…
continue reading
1
Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World
1:01:24
1:01:24
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:01:24
Dr. Sanduk Ruit of the Tilganga Institute in Kathmandu on restoring eyesight with affordable cataract surgery for the developing world.द्वारा Timmerman Report
…
continue reading
1
Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience
58:35
58:35
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
58:35
Ivana Magovcevic-Liebisch, CEO of Vigil Neuroscience, on precision neuroscience drug development.द्वारा Timmerman Report
…
continue reading
1
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing
59:21
59:21
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
59:21
Rahul Singhvi, CEO of Resilience, on rethinking the model for manufacturing of advanced biologics, gene and cell therapies.द्वारा Timmerman Report
…
continue reading
1
Ep114: Chris Gibson on Industrializing Drug Discovery
1:06:33
1:06:33
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:06:33
Chris Gibson, co-founder and CEO of Recursion, on using new tools to industrialize drug discovery.द्वारा Timmerman Report
…
continue reading
1
Ep113: Lewis Cantley & Siddhartha Mukherjee on Fighting Cancer with Food and Drugs
40:07
40:07
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
40:07
Lewis Cantley and Siddhartha Mukherjee, co-founders of Faeth Therapeutics, on fighting cancer with food and drug combinations.द्वारा Timmerman Report
…
continue reading
1
Ep112: Bernat Olle on Microbiome Therapeutics
1:06:26
1:06:26
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:06:26
Bernat Olle, CEO of Vedanta Biosciences, on developing microbiome therapeutics.द्वारा Timmerman Report
…
continue reading
1
Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery
1:02:42
1:02:42
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:02:42
Ray Stevens, CEO of ShouTi, on structural biology driven drug discovery.द्वारा Timmerman Report
…
continue reading
1
Ep110: Michele Andrasik on Making Clinical Trials More Diverse
1:07:25
1:07:25
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:07:25
Michele Andrasik, a clinical health psychologist at the Fred Hutchinson Cancer Research Center, on improving community outreach and diversity in clinical trials.द्वारा Timmerman Report
…
continue reading
1
Ep109: Derrell Porter on Cell Therapy Commercialization
1:08:52
1:08:52
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:08:52
Derrell Porter, CEO of CellEvolve, on a new approach to commercializing cell therapies.द्वारा Timmerman Report
…
continue reading
1
Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules
1:11:26
1:11:26
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
1:11:26
Praveen Tipirneni, CEO of Morphic Therapeutic, on targeting integrins with small molecules.द्वारा Timmerman Report
…
continue reading